For the first two months of this year, revenues from sales increased by 8% compared to the same period of 2016, including 5% decrease of domestic sales and 16% increase of export sales.

“We are very pleased with the results on the Russian market from the begining of this year and the trend is strenghtening in February reaching 40% increase in export sales.

• Medicines for Europe welcomes the European Parliament’s adoption of its report on ‘Options for improving access to medicines’ that places generic, biosimilar and value added medicines at the heart of the debate on access to medicines.

Тhe European Commission (EC) and the US Food and Drug Administration have reached an agreement which will enable EU and FDA to avoid the duplication of inspections of medicines manufacturing facilities in the two regions.

The EU Member States' authorities will recognise inspections made by US authorities, and vice versa.

for more information:

http://trade.ec.europa.eu/doclib/press/index.cfm?id=1629